Lexeo Therapeutics, Inc. - LXEO

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q2 2026 · Q1 2026

Value (USD)

Total reported value ($000)

$518.6M

QoQ value delta ($000)

+$59.51M (+12.96%)

Implied price effect (QoQ)

-3.18%

Total shares

93,302,912

QoQ shares delta

+13,336,794 (+16.68%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q2 2026 data: 143 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
CAXTON CORP	78,959	16,962	4.26%
MONTANOVA CAPITAL, LLC	29,718	6,384,200	0.54%
JANUS HENDERSON GROUP PLC	28,510	4,976,429	0.01%
Affinity Asset Advisors, LLC	27,034	5,807,611	1.22%
BlackRock, Inc.	26,717	5,739,455	0.0%
RA CAPITAL MANAGEMENT, L.P.	23,275	5,000,000	0.2%
Frazier Life Sciences Management, L.P.	22,459	4,824,725	0.49%
STATE STREET CORP	20,271	4,354,757	0.0%
Vestal Point Capital, LP	20,109	4,320,000	0.47%
Paradigm Biocapital Advisors LP	19,436	4,175,382	0.36%
Jupiter Topco LLC	18,409	3,954,691	0.01%
ORBIMED ADVISORS LLC	18,377	3,947,850	0.34%
CITADEL ADVISORS LLC	18,147	3,898,570	0.0%
VANGUARD CAPITAL MANAGEMENT LLC	14,551	3,125,893	0.0%
MILLENNIUM MANAGEMENT LLC	13,190	2,833,622	0.0%
Woodline Partners LP	11,639	2,500,532	0.04%
BALYASNY ASSET MANAGEMENT L.P.	11,231	2,412,742	0.01%
GOLDMAN SACHS GROUP INC	10,006	2,149,612	0.0%
683 Capital Management, LLC	8,728	1,875,000	0.43%
GEODE CAPITAL MANAGEMENT, LLC	8,138	1,747,959	0.0%
ADAR1 Capital Management, LLC	7,289	1,565,950	0.33%
Avoro Capital Advisors LLC	6,932	1,489,189	0.06%
Qube Research & Technologies Ltd	6,406	1,376,222	0.01%
Nantahala Capital Management, LLC	6,051	1,300,000	0.2%
DIMENSIONAL FUND ADVISORS LP	5,992	1,287,185	0.0%